GO:0048144 fibroblast proliferation: Fibrotic Expansion, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0048144 (fibroblast proliferation) describes the multiplication or reproduction of fibroblast cells, resulting in expansion of the fibroblast population.
• Fibroblast proliferation is a central driver of fibrosis across organs, including lung, kidney, heart, and skin.
• Mitochondrial dynamics, specifically Drp1-mediated fission, promote renal fibroblast activation and fibrogenesis.
• Signaling pathways such as IL6/JAK2/STAT3 and galectin-1 regulate fibroblast proliferation in keloids and lung fibrosis.
• Genetic tracing studies have identified distinct fibroblast subpopulations that clonally expand during pulmonary and cardiac fibrosis.
• Pharmacological agents like sorafenib and cesium can suppress fibroblast proliferation, highlighting therapeutic opportunities.
Description
Fibroblast proliferation (GO:0048144) is the biological process by which fibroblast cells multiply, leading to an expansion of the fibroblast population. This process is fundamental to tissue repair and remodeling, but when dysregulated it becomes a major driver of pathological fibrosis in multiple organs. The QuickGO definition captures this as the multiplication or reproduction of fibroblast cells, resulting in the expansion of the fibroblast population. Understanding the molecular and cellular mechanisms of fibroblast proliferation is critical for developing therapies against fibrotic diseases, which account for a significant proportion of global morbidity and mortality. Recent research has highlighted that fibroblast proliferation is not a uniform phenomenon; distinct subpopulations of fibroblasts can clonally expand and contribute differentially to fibrosis in the lung and heart. Moreover, the process is regulated by a complex interplay of mitochondrial dynamics, cytokine signaling, and extracellular matrix interactions. This article provides a research-grade overview of GO:0048144, integrating authoritative QuickGO data with verified PubMed literature to support researchers studying fibroblast biology and fibrosis.
fibroblast proliferation At A Glance
| GO ID | GO:0048144 |
|---|---|
| GO term | fibroblast proliferation |
| Ontology | biological_process |
| Synonym | none |
| Major function | Multiplication or reproduction of fibroblast cells, leading to expansion of the fibroblast population |
| Related processes | Fibrosis, wound healing, extracellular matrix deposition, cell cycle progression |
| Key regulators | Drp1, IL6/JAK2/STAT3, galectin-1, TSP1, sorafenib-sensitive pathways |
| Disease relevance | Pulmonary fibrosis, renal fibrosis, cardiac fibrosis, keloids, arthritis |
What Is GO:0048144?
According to the Gene Ontology, GO:0048144 (fibroblast proliferation) is defined as the multiplication or reproduction of fibroblast cells, resulting in the expansion of the fibroblast population. This process encompasses the cell cycle progression and division of fibroblasts, which are mesenchymal cells responsible for producing extracellular matrix components. Fibroblast proliferation is a normal component of wound healing and tissue repair, but its aberrant activation underlies fibrotic disorders in various organs.
Why Is fibroblast proliferation Important in Cell Biology?
Fibroblast proliferation is a double-edged sword: it is essential for normal tissue repair, but its chronic activation drives fibrosis, a leading cause of organ failure. In pulmonary fibrosis, clonal expansion of alveolar fibroblast progeny has been shown to drive disease progression in mouse models. In renal fibrosis, Drp1-mediated mitochondrial fission promotes fibroblast activation and fibrogenesis. Cardiac fibrosis involves unique fibroblast subpopulations that modulate the fibrotic response. Understanding the regulation of fibroblast proliferation at the molecular level is therefore critical for identifying therapeutic targets and developing interventions to halt or reverse fibrotic diseases.
• Fibroblast proliferation is a hallmark of fibrosis in lung, kidney, heart, and skin.
• It contributes to keloid formation through TSP1-mediated IL6/JAK2/STAT3 signaling.
• Galectin-1 inhibition attenuates lung fibroblast activation and proliferation, suggesting a therapeutic target.
• Drp1-mediated mitochondrial fission is required for renal fibroblast activation and fibrogenesis.
• Distinct fibroblast subpopulations clonally expand during cardiac fibrosis, offering insights into heterogeneity.
• Sorafenib suppresses fibroblast-like synoviocyte proliferation via cell cycle arrest, relevant to arthritis.
• Cesium suppresses fibroblast proliferation and migration, indicating environmental modulation.
• Fibroblast proliferation is a key process in wound healing and tissue remodeling.
• Targeting fibroblast proliferation may reduce extracellular matrix deposition and fibrosis progression.
• Genetic tracing tools enable lineage-specific study of fibroblast expansion in vivo.
What Happens During fibroblast proliferation?
Initiation and Activation
In simple terms: Fibroblasts receive signals that tell them to start dividing.
Fibroblast proliferation begins when quiescent fibroblasts are activated by growth factors, cytokines, or mechanical stress. In renal fibrosis, Drp1-mediated mitochondrial fission is an early event that promotes fibroblast activation and fibrogenesis. In keloids, TSP1 promotes fibroblast proliferation and extracellular matrix deposition via the IL6/JAK2/STAT3 signalling pathway. Galectin-1 also contributes to lung fibroblast activation and proliferation. These signals converge on cell cycle entry, often through cyclin-dependent kinase activation.
Cell Cycle Progression and Division
In simple terms: Activated fibroblasts go through the cell cycle and divide into two cells.
Once activated, fibroblasts progress through the G1/S transition and complete mitosis. Sorafenib suppresses the proliferation rate of fibroblast-like synoviocytes through arrest of the cell cycle in experimental adjuvant arthritis. This indicates that cell cycle checkpoints are critical control points for fibroblast proliferation. The process results in an increased number of fibroblasts, which then produce excessive extracellular matrix components.
Clonal Expansion and Heterogeneity
In simple terms: Some fibroblasts multiply more than others, leading to distinct subpopulations.
Recent genetic tracing studies have revealed that fibroblast proliferation is not uniform. In mouse models of pulmonary fibrosis, clonal expansion of alveolar fibroblast progeny drives the disease. In cardiac fibrosis, dual genetic tracing identified a unique fibroblast subpopulation that modulates the fibrotic response. These findings highlight that specific fibroblast subsets undergo preferential proliferation, contributing to disease heterogeneity.
Extracellular Matrix Deposition and Feedback
In simple terms: New fibroblasts produce matrix, which can further stimulate more proliferation.
Proliferating fibroblasts secrete extracellular matrix proteins, leading to tissue remodeling. In keloids, TSP1 promotes both fibroblast proliferation and extracellular matrix deposition, creating a positive feedback loop. This matrix deposition can further stimulate fibroblast activation and proliferation through integrin signaling and mechanical cues. The pathogenic expansion of fibroblasts fuels fibrosis, as reviewed in recent literature.
Resolution or Chronic Activation
In simple terms: Normally proliferation stops, but in disease it continues.
In normal wound healing, fibroblast proliferation is transient and resolves. However, in fibrotic diseases, proliferation becomes chronic and progressive. For example, in pulmonary fibrosis, fibroblast proliferation continues unabated, leading to destruction of lung architecture. Understanding the switch from transient to chronic proliferation is a major research focus.
Key Genes Involved in GO:0048144 fibroblast proliferation
The following genes and proteins have been experimentally implicated in the regulation or execution of fibroblast proliferation, based on verified PubMed literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| Drp1 (DNM1L) | Mitochondrial fission; promotes renal fibroblast activation and fibrogenesis | Target for inhibiting renal fibrosis |
| TSP1 (THBS1) | Promotes fibroblast proliferation and ECM deposition via IL6/JAK2/STAT3 in keloids | Therapeutic target for keloids |
| IL6 | Cytokine that signals through JAK2/STAT3 to drive fibroblast proliferation | Involved in keloid pathogenesis |
| JAK2 | Kinase in IL6 signaling pathway; mediates fibroblast proliferation | Potential target for anti-fibrotic therapy |
| STAT3 | Transcription factor downstream of JAK2; promotes fibroblast proliferation | Key mediator in keloids |
| Galectin-1 (LGALS1) | Inhibition attenuates lung fibroblast activation and proliferation | Target for lung fibrosis |
| Sorafenib target (e.g., RAF/PDGFR) | Sorafenib suppresses fibroblast-like synoviocyte proliferation via cell cycle arrest | Used in arthritis models |
| Cesium-sensitive pathway | Cesium suppresses fibroblast proliferation and migration | Environmental modulator |
| Alveolar fibroblast progeny markers | Clonal expansion drives pulmonary fibrosis | Lineage tracing in mouse models |
| Cardiac fibroblast subpopulation markers | Unique subpopulation modulates cardiac fibrosis | Dual genetic tracing |
| Cyclins (e.g., CCND1) | Cell cycle progression; targets of sorafenib-induced arrest | Readout for proliferation |
| CDKs (e.g., CDK4/6) | Cell cycle kinases; regulate G1/S transition | Potential drug targets |
| ECM components (e.g., Collagen I) | Produced by proliferating fibroblasts; feedback on proliferation | Marker of fibrosis |
| Integrins | Mediate mechanical signaling from ECM to fibroblasts | Potential modulators |
| Growth factors (e.g., TGF-beta) | Activate fibroblasts and promote proliferation | Central to fibrosis |
| PDGF | Potent mitogen for fibroblasts | Target of sorafenib |
| FGF | Promotes fibroblast proliferation | Involved in tissue repair |
| IL-6 receptor | Binds IL6 to initiate JAK2/STAT3 signaling | Target for blocking fibroblast proliferation |
How Is fibroblast proliferation Regulated?
Fibroblast proliferation is regulated by a complex network of signaling pathways, mitochondrial dynamics, and transcriptional programs. Drp1-mediated mitochondrial fission is a key upstream regulator in renal fibroblasts. The IL6/JAK2/STAT3 pathway is activated by TSP1 in keloids and promotes proliferation. Galectin-1 positively regulates lung fibroblast activation and proliferation. Pharmacological agents such as sorafenib induce cell cycle arrest, thereby suppressing proliferation. Cesium ions also suppress fibroblast proliferation and migration. These findings indicate that fibroblast proliferation is controlled at multiple levels, including receptor signaling, mitochondrial function, and cell cycle checkpoints.
fibroblast proliferation and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| Drp1 (DNM1L) | Renal fibrosis | Knockout or point mutation in renal fibroblasts |
| TSP1 (THBS1) | Keloids | Overexpression or knockout in keloid fibroblasts |
| Galectin-1 (LGALS1) | Lung fibrosis | Knockout in lung fibroblasts |
| Sorafenib targets (RAF/PDGFR) | Arthritis | Knock-in of resistance mutations in synoviocytes |
| Alveolar fibroblast markers | Pulmonary fibrosis | Lineage tracing knock-in in mice |
Pulmonary Fibrosis
Pulmonary fibrosis is characterized by excessive fibroblast proliferation and extracellular matrix deposition, leading to loss of lung function. Clonal expansion of alveolar fibroblast progeny has been shown to drive pulmonary fibrosis in mouse models. Galectin-1 inhibition attenuates lung fibroblast activation and proliferation, suggesting a potential therapeutic strategy. The pathogenic expansion of fibroblasts is a central mechanism in fibrosis.
Renal Fibrosis
In renal fibrosis, Drp1-mediated mitochondrial fission promotes fibroblast activation and fibrogenesis. This highlights the importance of mitochondrial dynamics in regulating fibroblast proliferation in the kidney. Targeting Drp1 may offer a novel approach to inhibit renal fibrosis.
Cardiac Fibrosis
Cardiac fibrosis involves a unique fibroblast subpopulation that modulates the fibrotic response, as revealed by dual genetic tracing. This subpopulation undergoes proliferation and contributes to pathological remodeling. Understanding the regulation of these cells is critical for developing targeted therapies.
Keloids and Skin Fibrosis
Keloids are characterized by excessive fibroblast proliferation and collagen deposition. TSP1 promotes fibroblast proliferation and extracellular matrix deposition via the IL6/JAK2/STAT3 signalling pathway in keloids. This pathway represents a potential target for keloid treatment.
From fibroblast proliferation-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does Drp1 mediate renal fibroblast proliferation? | Drp1 knockout or point mutation in renal fibroblasts |
| Does TSP1 drive keloid fibroblast proliferation via IL6/JAK2/STAT3? | TSP1 overexpression or knockout in keloid fibroblasts |
| Does galectin-1 inhibition reduce lung fibroblast proliferation? | Galectin-1 knockout in lung fibroblasts |
| Can sorafenib resistance reveal cell cycle targets? | Point mutation in sorafenib target kinases in synoviocytes |
| Which fibroblast subpopulations clonally expand in pulmonary fibrosis? | Knock-in lineage tracing in mice |
| How does cesium affect fibroblast proliferation? | Overexpression of cesium-sensitive channels in fibroblasts |
How to Study the fibroblast proliferation Process
| Method | What It Measures | Typical Application |
|---|---|---|
| EdU/BrdU incorporation | DNA synthesis | Quantifying fibroblast proliferation in vitro |
| MTT assay | Metabolic activity | Assessing cell viability and proliferation |
| Lineage tracing | Clonal expansion in vivo | Tracking fibroblast subpopulations in fibrosis |
| Western blot | Protein expression and phosphorylation | Analyzing IL6/JAK2/STAT3 signaling |
| Immunofluorescence | Protein localization and cell morphology | Detecting Drp1 in mitochondria |
| RNA-seq | Transcriptome-wide gene expression | Identifying proliferation-associated genes |
| Single-cell RNA-seq | Cell-to-cell heterogeneity | Discovering fibroblast subpopulations |
| Cell cycle analysis | DNA content and cell cycle phase | Evaluating sorafenib-induced arrest |
Cell Proliferation Assays
Common methods to measure fibroblast proliferation include BrdU incorporation, EdU staining, and MTT assays. These assays quantify DNA synthesis or metabolic activity and are used to assess the effect of genetic or pharmacological interventions.
Genetic Lineage Tracing
Dual genetic tracing and lineage tracing in mouse models allow researchers to track the expansion of specific fibroblast subpopulations in vivo. This approach has been used to identify clonal expansion of alveolar fibroblast progeny in pulmonary fibrosis and unique fibroblast subpopulations in cardiac fibrosis.
Molecular Signaling Analysis
Western blotting, immunoprecipitation, and reporter assays are used to study signaling pathways such as IL6/JAK2/STAT3 and mitochondrial fission proteins like Drp1. These methods help elucidate the molecular mechanisms regulating fibroblast proliferation.
Transcriptomics and Single-Cell Analysis
RNA-seq and single-cell RNA-seq can identify gene expression changes associated with fibroblast proliferation and heterogeneity. These techniques are valuable for discovering novel regulators and subpopulation-specific markers.
How CRISPR Can Be Used to Study GO:0048144 fibroblast proliferation
Knockout
CRISPR knockout of genes such as Drp1, TSP1, or galectin-1 can be used to determine their causal role in fibroblast proliferation. For example, Drp1 knockout in renal fibroblasts would test whether mitochondrial fission is required for fibrogenesis. Galectin-1 knockout in lung fibroblasts can validate its role in proliferation.
Point Mutation
Point mutations can be introduced to study specific phosphorylation sites or catalytic residues. For instance, mutating key residues in JAK2 or STAT3 could dissect the IL6 signaling pathway in keloid fibroblasts. Point mutations in Drp1 GTPase domain could clarify its role in mitochondrial fission during fibroblast activation.
Knock-in
Knock-in of reporter genes or tags allows lineage tracing and protein localization. Dual genetic tracing in mice uses knock-in of fluorescent reporters to track fibroblast subpopulations in cardiac fibrosis. Tagged knock-in of Drp1 could enable live imaging of mitochondrial dynamics.
Overexpression
Overexpression of TSP1 or galectin-1 in fibroblasts can mimic pathological conditions and test sufficiency in driving proliferation. Overexpression of constitutively active STAT3 could further activate the IL6/JAK2/STAT3 pathway.
How EDITGENE Supports fibroblast proliferation Research
Researchers studying fibroblast proliferation-related genes often need to determine whether a candidate gene is causally involved in the process or merely correlated with it. EDITGENE provides a comprehensive suite of CRISPR-based services to enable precise genetic manipulation in fibroblast models, from knockout to knock-in and overexpression, as well as library screening and bioinformatics support.
Contact EDITGENE today to design your custom CRISPR model for fibroblast proliferation research.
Frequently Asked Questions About fibroblast proliferation
What is GO:0048144?
GO:0048144 is the Gene Ontology term for fibroblast proliferation, defined as the multiplication or reproduction of fibroblast cells, resulting in the expansion of the fibroblast population.
What genes are involved in fibroblast proliferation?
Key genes include Drp1 (DNM1L), TSP1 (THBS1), IL6, JAK2, STAT3, and galectin-1 (LGALS1), among others.
How is fibroblast proliferation regulated?
It is regulated by signaling pathways such as IL6/JAK2/STAT3, mitochondrial dynamics (Drp1), and cell cycle checkpoints.
What diseases are associated with fibroblast proliferation?
Fibroblast proliferation is associated with pulmonary fibrosis, renal fibrosis, cardiac fibrosis, keloids, and arthritis.
How can I study fibroblast proliferation in the lab?
Common methods include EdU/BrdU incorporation, MTT assays, lineage tracing, Western blotting, and RNA-seq.
What is the role of Drp1 in fibroblast proliferation?
Drp1-mediated mitochondrial fission promotes renal fibroblast activation and fibrogenesis.
Does TSP1 affect fibroblast proliferation?
Yes, TSP1 promotes fibroblast proliferation and extracellular matrix deposition via the IL6/JAK2/STAT3 signalling pathway in keloids.
Can galectin-1 inhibition reduce fibroblast proliferation?
Inhibition of galectin-1 attenuates lung fibroblast activation and proliferation in lung fibrosis.
What is the effect of sorafenib on fibroblast proliferation?
Sorafenib suppresses the proliferation rate of fibroblast-like synoviocytes through cell cycle arrest in experimental adjuvant arthritis.
How does cesium affect fibroblast proliferation?
Cesium suppresses fibroblast proliferation and migration.
Conclusion
Fibroblast proliferation (GO:0048144) is a fundamental biological process that underlies both normal tissue repair and pathological fibrosis. The integration of QuickGO definitions with verified PubMed literature reveals a complex regulatory network involving mitochondrial dynamics, cytokine signaling, and cell cycle control. Key genes such as Drp1, TSP1, IL6, JAK2, STAT3, and galectin-1 have been experimentally linked to fibroblast proliferation in various disease contexts. Understanding these mechanisms is essential for developing targeted therapies against fibrotic diseases. EDITGENE offers a comprehensive suite of CRISPR services to facilitate functional studies of fibroblast proliferation-related genes, from knockout to knock-in and overexpression, enabling researchers to dissect causal relationships and identify novel therapeutic targets.
References
- 1. Schott CA et al.. 2025. Pathogenic expansion: fibroblast proliferation fuels fibrosis.. J Clin Invest 135(22) PMID: 41243968
- 2. Wang Y et al.. 2020. Drp1-mediated mitochondrial fission promotes renal fibroblast activation and fibrogenesis.. Cell Death Dis 11(1):29 PMID: 31949126
- 3. Khatun Z et al.. 2020. Cesium suppresses fibroblast proliferation and migration.. Fukushima J Med Sci 66(2):97-102 PMID: 32624528
- 4. Molina C et al.. 2025. Clonal expansion of alveolar fibroblast progeny drives pulmonary fibrosis in mouse models.. J Clin Invest 135(22) PMID: 40875468
- 5. Feng QL et al.. 2022. TSP1 promotes fibroblast proliferation and extracellular matrix deposition via the IL6/JAK2/STAT3 signalling pathway in keloids.. Exp Dermatol 31(10):1533-1542 PMID: 35661430
- 6. Xue J et al.. 2023. Inhibition of Galectin-1 attenuates lung fibroblast activation and proliferation in lung fibrosis.. Cell Mol Biol (Noisy-le-grand) 69(11):213-218 PMID: 38015516
- 7. Han M et al.. 2023. Dual genetic tracing reveals a unique fibroblast subpopulation modulating cardiac fibrosis.. Nat Genet 55(4):665-678 PMID: 36959363
- 8. Gong Y et al.. 2021. Sorafenib suppresses proliferation rate of fibroblast-like synoviocytes through the arrest of cell cycle in experimental adjuvant arthritis.. J Pharm Pharmacol 73(1):32-39 PMID: 33791811
